Glazer Capital »

Day One Biopharmaceuticals I shares owned by Glazer Capital

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Glazer Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $100M 4.7M 21.44

More positions owned by Glazer Capital

Air Lease Corp Cl A
Hologic
Sealed Air
Clearwater Analytics Hldgs I Cl A (CWAN)
Amicus Therapeutics (FOLD)
Onestream Cl A
Arcellx Common Stock (ACLX)
Brighthouse Finl (BHF)
Digitalbridge Group Cl A New (DBRG)
Terns Pharmaceuticals (TERN)
Tri Pointe Homes (TPH)
Day One Biopharmaceuticals I (DAWN)
Electronic Arts (EA)
Semrush Hldgs Cl A Com (SEMR)
Select Medical Holdings Corporation (SEM)

View all positions for Glazer Capital

Top funds holding Day One Biopharmaceuticals I

BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
FMR
Glazer Capital
State Street Corporation
Deerfield Management Company
Vanguard Capital Management
Balyasny Asset Management
CNH Partners
UBS Group
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
Bank of America Corporation

View all funds holding Day One Biopharmaceuticals I